Evolus Inc (FRA:EVL)
€ 15.6 1.1 (7.59%) Market Cap: 954.28 Mil Enterprise Value: 984.11 Mil PE Ratio: 0 PB Ratio: 54.80 GF Score: 55/100

Q2 2022 Evolus Inc Earnings Call Transcript

Aug 02, 2022 / 01:00PM GMT
Release Date Price: €12.7 (-2.31%)
Operator

Greetings. Welcome to the Evolus Second Quarter 2022 Earnings Call. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the conference over to your host, David Erickson, Vice President, Investor Relations. You may begin.

David K. Erickson
Evolus, Inc. - VP of IR

Thank you, operator, and welcome to everyone joining us on today's call. With me today are David Moatazedi, President and Chief Executive Officer; and Rui Avelar, Chief Medical Officer and Head of R&D.

Our prepared remarks today will include forward-looking statements within the meaning of United States securities laws, and management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the company's business, strategy, operations or financial performance. A detailed discussion of the risks and uncertainties that the company faces is contained in its Annual Report on Form 10-K,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot